CRE Homepage About The CRE Advisory Board Newsletter Search Links Representation Comments/Ideas
Data Access
Data Quality
Regulation by Litigation
Regulation by Appropriation
Special Projects
CRE Watch List
OMB Papers
Abstracts and Reviews
Regulatory Review
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Consumer Response Service
Site Search

Enter keyword(s) to search

®: CRE Regulatory Action of the Week

Report Questions Whether FDA Equipped To Regulate Nano
On October 6, 2006, the Woodrow Wilson International Center for Scholarsí Project on emerging Technologies released a report which argues that the Food and Drug Administration does not have the legal, resource and scientific tools needed to regulate nanotechnology. The reportís release is coincidental with the FDA public hearing on regulating nano, which is to be held on October 10, 2006.

  • Click to read Woodrow Wilson website on report, and to download copy of report
  • Click to read RegWeek on FDA Nano Meeting